NFE2L2 and systemic lupus erythematosus: These include development of an SLE-like autoimmune disorder and inflammation in Nrf2-deficient mice, downregulation of Nrf2 protein abundance and target gene expression in animal models of SLE, and the effects of Nrf2-inducing agents to combat oxidative and inflammation markers and SLE pathogenesis.